ArticleACS nano2026
Automated and Parallelized Microfluidic Generation of Large and Precisely Defined Lipid Nanoparticle Libraries.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.ChemMedChem · 2026Review
- Navigating Lipid Nanostructure Design Space Through Continuous Microfluidic Automation.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Open-source robotic chip-to-plate interface for high-throughput microfluidic generation of materials libraries.bioRxiv : the preprint server for biology · 2026Article
- Microfluidic and Turbulent Mixing for mRNA LNP Vaccines.Pharmaceutics · 2025Review
Corrections and comments
- Update of
Authors and funding
16 authors.
Funding
Abstract
Lipid nanoparticles (LNPs) are being developed for a broad set of therapeutic applications by changing both the structures of the lipids used to formulate each LNP and their relative proportions. Because lipid synthesis and in vivo screening have been parallelized using combinatorial chemistry and LNP barcoding, respectively, the manual and sequential microfluidic formulation of LNPs remains the primary rate-limiting step during early-stage discovery. In this work, we present a parallelized, automated microfluidic platform capable of generating large, precisely defined LNP libraries in parallel, with throughput on the order of 1000 distinct formulations per hour. Each formulation is defined by varying the reagent flow ratios into one of eight microscale mixers using lithographically encoded fluidic resistors and dynamically controlled external pressure supplies. The microfluidic chip is integrated with custom robotic plate handling for the rapid collection of each distinct formulation. To evaluate this platform, we characterized 96 formulations generated on-chip in terms of both physicochemical properties and transfection efficiency in vitro. We further validated our lead candidate against the state of the art in vivo. We demonstrate the ability to rapidly discover a formulation and scale its production to liters per hour under identical mixing conditions, bridging from early discovery to manufacturing through microfluidic parallelization.
Indexed as
Identifiers
41453807What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.